• Login
    View Item 
    •   Treasures Home
    • Academic Schools and Programs
    • School of Behavioral and Brain Sciences
    • BBS Faculty Research
    • Price, Theodore J.
    • View Item
    •   Treasures Home
    • Academic Schools and Programs
    • School of Behavioral and Brain Sciences
    • BBS Faculty Research
    • Price, Theodore J.
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The Antidiabetic Drug Metformin Prevents and Reverses Neuropathic Pain and Spinal Cord Microglial Activation in Male but not Female Mice

    Thumbnail
    View/Open
    Link to Article (185.0Kb)
    Date
    2018-11-01
    Author
    Inyang, Kufreobong E.
    Szabo-Pardi, Thomas
    Wentworth, Emma
    McDougal, Timothy A.
    Dussor, Gregory
    Burton, Michael D.
    Price, Theodore J.
    Metadata
    Show full item record
    Abstract
    Abstract
    Metformin is a widely prescribed drug used in the treatment of type II diabetes. While the drug has many mechanisms of action, most of these converge on AMP activated protein kinase (AMPK), which metformin activates. AMPK is a multifunctional kinase that is a negative regulator of mechanistic target of rapamycin (mTOR) and mitogen activated protein kinase (MAPK) signaling. Activation of AMPK decreases the excitability of dorsal root ganglion neurons and AMPK activators are effective in reducing chronic pain in inflammatory, post-surgical and neuropathic rodent models. We have previously shown that metformin leads to an enduring resolution of neuropathic pain in the spared nerve injury (SNI) model in male mice and rats. The precise mechanism underlying this long-lasting effect is not known. We conducted experiments to investigate the effects of metformin on SNI-induced microglial activation, a process implicated in the maintenance of neuropathic pain that has recently been shown to be sexually dimorphic. We find that metformin is effective at inhibiting development of neuropathic pain when treatment is given around the time of injury and that metformin is likewise effective at reversing neuropathic mechanical hypersensitivity when treatment is initiation weeks after injury. This effect is linked to decreased Iba-1 staining in the dorsal horn, a marker of microglial activation. Importantly, these positive behavioral and microglia effects of metformin were only observed in male mice. We conclude that the neuropathic pain modifying effects of metformin are sex-specific supporting a differential role for microglial activation in male and female mice.
    Description
    Due to copyright restrictions and/or publisher's policy full text access from Treasures at UT Dallas is limited to current UTD affiliates (use the provided Link to Article).
    URI
    http://dx.doi.org/10.1016/j.phrs.2018.10.027
    https://hdl.handle.net/10735.1/8784
    Collections
    • CAPS Research
    • Dussor, Gregory
    • Price, Theodore J.

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV
     

     

    Browse

    All of TreasuresCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login

    DSpace software copyright © 2002-2016  DuraSpace
    Contact Us | Send Feedback
    Theme by 
    Atmire NV